Global Montelukast Drug Sales Market Report 2021

1 Montelukast Drug Market Overview

• 1.1 Montelukast Drug Product Scope
• 1.2 Montelukast Drug Segment by Type
  • 1.2.1 Global Montelukast Drug Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Tablets
  • 1.2.3 Oral Granules
• 1.3 Montelukast Drug Segment by Application
  • 1.3.1 Global Montelukast Drug Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Hospital
  • 1.3.3 Drug Store
  • 1.3.4 Others
• 1.4 Montelukast Drug Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Montelukast Drug Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Montelukast Drug Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Montelukast Drug Price Trends (2016-2027)

2 Montelukast Drug Estimates and Forecasts by Region

• 2.1 Global Montelukast Drug Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Montelukast Drug Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Montelukast Drug Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Montelukast Drug Revenue Market Share by Region (2016-2021)
• 2.3 Global Montelukast Drug Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Montelukast Drug Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Montelukast Drug Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Montelukast Drug Estimates and Projections (2016-2027)
  • 2.4.2 Europe Montelukast Drug Estimates and Projections (2016-2027)
  • 2.4.3 China Montelukast Drug Estimates and Projections (2016-2027)
  • 2.4.4 Japan Montelukast Drug Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Montelukast Drug Estimates and Projections (2016-2027)
  • 2.4.6 India Montelukast Drug Estimates and Projections (2016-2027)

3 Global Montelukast Drug Competition Landscape by Players

• 3.1 Global Top Montelukast Drug Players by Sales (2016-2021)
• 3.2 Global Top Montelukast Drug Players by Revenue (2016-2021)
• 3.3 Global Montelukast Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Montelukast Drug as of 2020)
• 3.4 Global Montelukast Drug Average Price by Company (2016-2021)
• 3.5 Manufacturers Montelukast Drug Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Montelukast Drug Market Size by Type

• 4.1 Global Montelukast Drug Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Montelukast Drug Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Montelukast Drug Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Montelukast Drug Price by Type (2016-2021)
• 4.2 Global Montelukast Drug Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Montelukast Drug Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Montelukast Drug Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Montelukast Drug Price Forecast by Type (2022-2027)

5 Global Montelukast Drug Market Size by Application

• 5.1 Global Montelukast Drug Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Montelukast Drug Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Montelukast Drug Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Montelukast Drug Price by Application (2016-2021)
• 5.2 Global Montelukast Drug Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Montelukast Drug Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Montelukast Drug Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Montelukast Drug Price Forecast by Application (2022-2027)

6 North America Montelukast Drug Market Facts & Figures

• 6.1 North America Montelukast Drug Sales by Company
  • 6.1.1 North America Montelukast Drug Sales by Company (2016-2021)
  • 6.1.2 North America Montelukast Drug Revenue by Company (2016-2021)
• 6.2 North America Montelukast Drug Sales Breakdown by Type
  • 6.2.1 North America Montelukast Drug Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Montelukast Drug Sales Breakdown by Type (2022-2027)
• 6.3 North America Montelukast Drug Sales Breakdown by Application
  • 6.3.1 North America Montelukast Drug Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Montelukast Drug Sales Breakdown by Application (2022-2027)

7 Europe Montelukast Drug Market Facts & Figures

• 7.1 Europe Montelukast Drug Sales by Company
  • 7.1.1 Europe Montelukast Drug Sales by Company (2016-2021)
  • 7.1.2 Europe Montelukast Drug Revenue by Company (2016-2021)
• 7.2 Europe Montelukast Drug Sales Breakdown by Type
  • 7.2.1 Europe Montelukast Drug Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Montelukast Drug Sales Breakdown by Type (2022-2027)
• 7.3 Europe Montelukast Drug Sales Breakdown by Application
  • 7.3.1 Europe 146 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 146 Sales Breakdown by Application (2022-2027)

8 China Montelukast Drug Market Facts & Figures

• 8.1 China Montelukast Drug Sales by Company
  • 8.1.1 China Montelukast Drug Sales by Company (2016-2021)
  • 8.1.2 China Montelukast Drug Revenue by Company (2016-2021)
• 8.2 China Montelukast Drug Sales Breakdown by Type
  • 8.2.1 China Montelukast Drug Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Montelukast Drug Sales Breakdown by Type (2022-2027)
• 8.3 China Montelukast Drug Sales Breakdown by Application
  • 8.3.1 China 174 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 174 Sales Breakdown by Application (2022-2027)

9 Japan Montelukast Drug Market Facts & Figures

• 9.1 Japan Montelukast Drug Sales by Company
  • 9.1.1 Japan Montelukast Drug Sales by Company (2016-2021)
  • 9.1.2 Japan Montelukast Drug Revenue by Company (2016-2021)
• 9.2 Japan Montelukast Drug Sales Breakdown by Type
  • 9.2.1 Japan Montelukast Drug Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Montelukast Drug Sales Breakdown by Type (2022-2027)
• 9.3 Japan Montelukast Drug Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Montelukast Drug Market Facts & Figures

• 10.1 Southeast Asia Montelukast Drug Sales by Company
  • 10.1.1 Southeast Asia Montelukast Drug Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Montelukast Drug Revenue by Company (2016-2021)
• 10.2 Southeast Asia Montelukast Drug Sales Breakdown by Type
  • 10.2.1 Southeast Asia Montelukast Drug Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Montelukast Drug Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Montelukast Drug Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Montelukast Drug Market Facts & Figures

• 11.1 India Montelukast Drug Sales by Company
  • 11.1.1 India Montelukast Drug Sales by Company (2016-2021)
  • 11.1.2 India Montelukast Drug Revenue by Company (2016-2021)
• 11.2 India Montelukast Drug Sales Breakdown by Type
  • 11.2.1 India Montelukast Drug Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Montelukast Drug Sales Breakdown by Type (2022-2027)
• 11.3 India Montelukast Drug Sales Breakdown by Application
  • 11.3.1 India Montelukast Drug Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Montelukast Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Montelukast Drug Business

• 12.1 Merck & Co.
  • 12.1.1 Merck & Co. Corporation Information
  • 12.1.2 Merck & Co. Business Overview
  • 12.1.3 Merck & Co. Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Merck & Co. Montelukast Drug Products Offered
  • 12.1.5 Merck & Co. Recent Development
• 12.2 Teva
  • 12.2.1 Teva Corporation Information
  • 12.2.2 Teva Business Overview
  • 12.2.3 Teva Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Teva Montelukast Drug Products Offered
  • 12.2.5 Teva Recent Development
• 12.3 Mylan
  • 12.3.1 Mylan Corporation Information
  • 12.3.2 Mylan Business Overview
  • 12.3.3 Mylan Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Mylan Montelukast Drug Products Offered
  • 12.3.5 Mylan Recent Development
• 12.4 Glenmark Pharmaceuticals
  • 12.4.1 Glenmark Pharmaceuticals Corporation Information
  • 12.4.2 Glenmark Pharmaceuticals Business Overview
  • 12.4.3 Glenmark Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Glenmark Pharmaceuticals Montelukast Drug Products Offered
  • 12.4.5 Glenmark Pharmaceuticals Recent Development
• 12.5 Hikma Group
  • 12.5.1 Hikma Group Corporation Information
  • 12.5.2 Hikma Group Business Overview
  • 12.5.3 Hikma Group Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Hikma Group Montelukast Drug Products Offered
  • 12.5.5 Hikma Group Recent Development
• 12.6 Sandoz
  • 12.6.1 Sandoz Corporation Information
  • 12.6.2 Sandoz Business Overview
  • 12.6.3 Sandoz Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Sandoz Montelukast Drug Products Offered
  • 12.6.5 Sandoz Recent Development
• 12.7 Torrent Pharmaceuticals
  • 12.7.1 Torrent Pharmaceuticals Corporation Information
  • 12.7.2 Torrent Pharmaceuticals Business Overview
  • 12.7.3 Torrent Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Torrent Pharmaceuticals Montelukast Drug Products Offered
  • 12.7.5 Torrent Pharmaceuticals Recent Development
• 12.8 Lannett Company
  • 12.8.1 Lannett Company Corporation Information
  • 12.8.2 Lannett Company Business Overview
  • 12.8.3 Lannett Company Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Lannett Company Montelukast Drug Products Offered
  • 12.8.5 Lannett Company Recent Development
• 12.9 Apotex
  • 12.9.1 Apotex Corporation Information
  • 12.9.2 Apotex Business Overview
  • 12.9.3 Apotex Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Apotex Montelukast Drug Products Offered
  • 12.9.5 Apotex Recent Development
• 12.10 Dr. Reddys Laboratories
  • 12.10.1 Dr. Reddys Laboratories Corporation Information
  • 12.10.2 Dr. Reddys Laboratories Business Overview
  • 12.10.3 Dr. Reddys Laboratories Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Dr. Reddys Laboratories Montelukast Drug Products Offered
  • 12.10.5 Dr. Reddys Laboratories Recent Development
• 12.11 Aurobindo Pharma
  • 12.11.1 Aurobindo Pharma Corporation Information
  • 12.11.2 Aurobindo Pharma Business Overview
  • 12.11.3 Aurobindo Pharma Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Aurobindo Pharma Montelukast Drug Products Offered
  • 12.11.5 Aurobindo Pharma Recent Development
• 12.12 Accord Healthcare
  • 12.12.1 Accord Healthcare Corporation Information
  • 12.12.2 Accord Healthcare Business Overview
  • 12.12.3 Accord Healthcare Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Accord Healthcare Montelukast Drug Products Offered
  • 12.12.5 Accord Healthcare Recent Development
• 12.13 Hetero
  • 12.13.1 Hetero Corporation Information
  • 12.13.2 Hetero Business Overview
  • 12.13.3 Hetero Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 Hetero Montelukast Drug Products Offered
  • 12.13.5 Hetero Recent Development
• 12.14 Unimark
  • 12.14.1 Unimark Corporation Information
  • 12.14.2 Unimark Business Overview
  • 12.14.3 Unimark Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 Unimark Montelukast Drug Products Offered
  • 12.14.5 Unimark Recent Development
• 12.15 Ajanta Pharma
  • 12.15.1 Ajanta Pharma Corporation Information
  • 12.15.2 Ajanta Pharma Business Overview
  • 12.15.3 Ajanta Pharma Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.15.4 Ajanta Pharma Montelukast Drug Products Offered
  • 12.15.5 Ajanta Pharma Recent Development
• 12.16 MACLEODS
  • 12.16.1 MACLEODS Corporation Information
  • 12.16.2 MACLEODS Business Overview
  • 12.16.3 MACLEODS Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.16.4 MACLEODS Montelukast Drug Products Offered
  • 12.16.5 MACLEODS Recent Development
• 12.17 Jubilant Pharma
  • 12.17.1 Jubilant Pharma Corporation Information
  • 12.17.2 Jubilant Pharma Business Overview
  • 12.17.3 Jubilant Pharma Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.17.4 Jubilant Pharma Montelukast Drug Products Offered
  • 12.17.5 Jubilant Pharma Recent Development
• 12.18 Unichem Laboratories
  • 12.18.1 Unichem Laboratories Corporation Information
  • 12.18.2 Unichem Laboratories Business Overview
  • 12.18.3 Unichem Laboratories Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.18.4 Unichem Laboratories Montelukast Drug Products Offered
  • 12.18.5 Unichem Laboratories Recent Development
• 12.19 Amneal Pharmaceuticals
  • 12.19.1 Amneal Pharmaceuticals Corporation Information
  • 12.19.2 Amneal Pharmaceuticals Business Overview
  • 12.19.3 Amneal Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.19.4 Amneal Pharmaceuticals Montelukast Drug Products Offered
  • 12.19.5 Amneal Pharmaceuticals Recent Development
• 12.20 Shanghai Anbison Lab
  • 12.20.1 Shanghai Anbison Lab Corporation Information
  • 12.20.2 Shanghai Anbison Lab Business Overview
  • 12.20.3 Shanghai Anbison Lab Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.20.4 Shanghai Anbison Lab Montelukast Drug Products Offered
  • 12.20.5 Shanghai Anbison Lab Recent Development
• 12.21 Perrigo
  • 12.21.1 Perrigo Corporation Information
  • 12.21.2 Perrigo Business Overview
  • 12.21.3 Perrigo Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.21.4 Perrigo Montelukast Drug Products Offered
  • 12.21.5 Perrigo Recent Development
• 12.22 Cipla
  • 12.22.1 Cipla Corporation Information
  • 12.22.2 Cipla Business Overview
  • 12.22.3 Cipla Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.22.4 Cipla Montelukast Drug Products Offered
  • 12.22.5 Cipla Recent Development
• 12.23 CSPC Ouyi Pharmaceutical
  • 12.23.1 CSPC Ouyi Pharmaceutical Corporation Information
  • 12.23.2 CSPC Ouyi Pharmaceutical Business Overview
  • 12.23.3 CSPC Ouyi Pharmaceutical Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.23.4 CSPC Ouyi Pharmaceutical Montelukast Drug Products Offered
  • 12.23.5 CSPC Ouyi Pharmaceutical Recent Development

13 Montelukast Drug Manufacturing Cost Analysis

• 13.1 Montelukast Drug Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Montelukast Drug
• 13.4 Montelukast Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Montelukast Drug Distributors List
• 14.3 Montelukast Drug Customers

15 Market Dynamics

• 15.1 Montelukast Drug Market Trends
• 15.2 Montelukast Drug Drivers
• 15.3 Montelukast Drug Market Challenges
• 15.4 Montelukast Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List